New Tool Gauges Post –CAR T Relapse Risk in Multiple Myeloma New Tool Gauges Post –CAR T Relapse Risk in Multiple Myeloma

A simple prediction model developed with US and European cohorts effectively predicted relapse risk in multiple myeloma patients post anti-BCMA CAR-T therapy.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news